Treatments for colorectal liver metastases: A new focus on a familiar concept

Critical Reviews in Oncology/Hematology

Volumn 108, Issue , 2016, Pages 154-163

  Zampino, M G ^a   Magni, E ^b   Ravenda, P S ^a   Cella, C A ^a   Bonomo, G ^a   Della Vigna, P ^a   Galdy, S ^a   Spada, F ^a   Varano, G M ^a   Mauri, G ^a   Fazio, N ^a   Orsi, F ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Ablative therapies; Intra arterial chemotherapy; Liver metastases; Loco regional therapies; Radio embolization

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN; YTTRIUM 90;

ABLATION THERAPY; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CHEMOEMBOLIZATION; COLORECTAL CANCER; DRUG DELIVERY SYSTEM; DRUG ELUTING BEAD; EVIDENCE BASED MEDICINE; HEPATIC ARTERY; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; MINIMALLY INVASIVE PROCEDURE; NEOADJUVANT THERAPY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE CARE; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELECTIVE INTERNAL RADIATION THERAPY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; LIVER NEOPLASMS; LIVER RESECTION; PATHOLOGY; QUALITY OF LIFE; SECONDARY;

CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; QUALITY OF LIFE;

EID: 85006333162     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2016.11.005     Document Type: Review

References (89)

1. Abdalla, E.K., Bauer, T.W., Chun, Y.S., D'Angelica, M., Kooby, D.A., Jarnagin, W.R., Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) 15:February (2) (2013), 119–130.
2. Adam, R., Pascal, G., Castaing, D., Azoulay, D., Delvart, V., Paule, B., Levi, F., Bismuth, H., Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann. Surg. 240:December (6) (2004), 1052–1061 discussion 1061-4.
3. Adam, R., Delvart, V., Pascal, G., Valeanu, A., Castaing, D., Azoulay, D., Giacchetti, S., Paule, B., Kunstlinger, F., Ghémard, O., Levi, F., Bismuth, H., Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg. 240:October (4) (2004), 644–657 discussion 657-8.
4. Ahmed, M., Solbiati, L., Brace, C.L., Breen, D.J., Callstrom, M.R., Charboneau, J.W., Chen, M.H., Choi, B.I., de Baère, T., Dodd 3rd, G.D., Dupuy, D.E., Gervais, D.A., Gianfelice, D., Gillams, A.R., Lee, F.T. Jr., Leen, E., Lencioni, R., Littrup, P.J., Livraghi, T., Lu, D.S., McGahan, J.P., Meloni, M.F., Nikolic, B., Pereira, P.L., Liang Rhim Rose, P.H.S.C., Salem, R., Sofocleous, C.T., Solomon, S.B., Soulen, M.C., Tanaka, M., Vogl, T.J., Wood, B.J., Goldberg, S.N., International working group on image-Guided tumor ablation; interventional oncology sans frontières expert panel; technology assessment committee of the society of interventional radiology; standard of practice committee of the cardiovascular and interventional radiological society of europe. image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. J. Vasc. Interv. Radiol. 25:November (11) (2014), 1691–1705.
5. Akinwande, O.K., Philips, P., Duras, P., Pluntke, S., Scoggins, C., Martin, R.C., Small versus large-sized drug-eluting beads (DEBIRI) for the treatment of hepatic colorectal metastases: a propensity score matching analysis. Cardiovasc. Intervent. Radiol. 38:April (2) (2015), 361–371.
6. Albert, M., Kiefer, M.V., Sun, W., Haller, D., Fraker, D.L., Tuite, C.M., Stavropoulos, S.W., Mondschein, J.I., Soulen MCC Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer 117:January (1) (2011), 343–352.
7. Alberts, S.R., Roh, M.S., Mahoney, M.R., et al. Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a north central cancer treatment group (NCCTG)/national surgical adjuvant breast and bowel project (NSABP) phase II intergroup trial, N9945/CI-66. J. Clin. Oncol. 28 (2010), 853–858.
8. ®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study. Anticancer Res. 31:December (12) (2011), 4581–4587.
9. Ammori, J.B., Kemeny, N.E., Fong, Y., Cercek, A., Dematteo, R.P., Allen, P.J., Kingham, T.P., Gonen, M., Paty, P.B., Jarnagin, W.R., D'Angelica, M.I., Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. Ann. Surg. Oncol. 20:September (9) (2013), 2901–2907.
10. Bai, H., Huangz, X., Jing, L., Zeng, Q., Han, L., The effect of radiofrequency ablation v.s. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis. Hepatogastroenterology 62:March–April (138) (2015), 373–377.
11. Berber, E., Pelley, R., Siperstein, A.E., Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J. Clin. Oncol. 23:March (7) (2005), 1358–1364.
12. Bigourdan, J.M., Faber, B., Rayar, M., Chirpaz, E., Boucher, E., Boudjema, K., Disease-free survival after simultaneous or delayed resection of synchronous colorectal liver metastasis and primary cancer. Hepatogastroenterology 61:June (132) (2014), 1074–1081.
13. Boige, V., Malka, D., Elias, D., Castaing, M., De Baere, T., Goere, D., Dromain, C., Pocard, M., Ducreux, M., Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann. Surg. Oncol. 15:January (1) (2008), 219–226.
14. Chang, A.E., Schneider, P.D., Sugarbaker, P.H., Simpson, C., Culnane, M., Steinberg, S.M., A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann. Surg. 206:December (6) (1987), 685–693.
15. Chang, D.T., Swaminath, A., Kozak, M., Weintraub, J., Koong, A.C., Kim, J., Dinniwell, R., Brierley, J., Kavanagh, B.D., Dawson, L.A., Schefter, T.E., Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117:September (17) (2011), 4060–4069.
16. Charnsangavej, C., Clary, B., Fong, Y., Grothey, A., Pawlik, T.M., Choti, M.A., Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann. Surg. Oncol. 13:October (10) (2006), 1261–1268.
17. Cosimelli, M., Golfieri, R., Cagol, P.P., Carpanese, L., Sciuto, R., Maini, C.L., Mancini, R., Sperduti, I., Pizzi, G., Diodoro, M.G., Perrone, M., Giampalma, E., Angelelli, B., Fiore, F., Lastoria, S., Bacchetti, S., Gasperini, D., Geatti, O., Izzo, F., Italian Society of Locoregional Therapies in Oncology (SITILO), Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br. J. Cancer 27:July (3) (2010), 324–331.
18. Delbaldo, C., Ychou, M., Zawadi, A., Douillard, J.Y., André, T., Guerin-Meyer, V., Rougier, P., Dupuis, O., Faroux, R., Jouhaud, A., Quinaux, E., Buyse, M., Piedbois, P., AERO, GERCOR, FNLCC and FFCD. Postoperative irinotecan in resected stage II-III rectal cancer. Final analysis of the French R98 intergroup trial. Ann Onco 26:June (6) (2015), 1208–1215.
19. Ducreux, M., Ychou, M., Laplanche, A., Gamelin, E., Lasser, P., Husseini, F., Quenet, F., Viret, F., Jacob, J.H., Boige, V., Elias, D., Delperro, J.R., Luboinski, M., gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer, Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic Hetastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le. Cancer. J Clin Oncol. 23:August (22) (2005), 4881–4887.
20. Ensminger, W.D., Gyves, J.W., Clinical pharmacology of hepatic arterial chemotherapy. Semin. Oncol. 10:June (2) (1983), 176–182.
21. Fazio, N., Orsi, F., Grasso, R.F., Ferretti, G., Medici, M., Rocca, A., Zampino, G., Curigliano, G., De Pas, T., Colleoni, M., Bonomo, G., Marrocco, E., Lunghi, L., De Braud, F., Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinoma. Anticancer Res. 23:Nov-Dec(6D) (2003), 5023–5030.
22. Fiorentini, G., Aliberti, C., Tilli, M., Mulazzani, L., Graziano, F., Giordani, P., Mambrini, A., Montagnani, F., Alessandroni, P., Catalano, V., Coschiera, P., Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res. 32:April (4) (2012), 1387–1395.
23. Fiorentini, G., A new tool to enhance the efficacy of chemoembolization to treat primary and metastatic hepatic tumors. Expert Opin. Drug Deliv. 8:April (4) (2011), 409–413.
24. Folprecht, G., Gruenberger, T., Bechstein, W.O., Raab, H.R., Lordick, F., Hartmann, J.T., Lang, H., Frilling, A., Stoehlmacher, J., Weitz, J., Konopke, R., Stroszczynski, C., Liersch, T., Ockert, D., Herrmann, T., Goekkurt, E., Parisi, F., Köhne, C.H., Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 11:January (1) (2010), 38–47.
25. Garlipp, B., de Baere, T., Damm, R., Irmscher, R., van Buskirk, M., Stübs, P., Deschamps, F., Meyer, F., Seidensticker, R., Mohnike, K., Pech, M., Amthauer, H., Lippert, H., Ricke, J., Seidensticker, M., Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. Hepatology 59:May (5) (2014), 1864–1873.
26. Gillams, A.R., Lees, W.R., Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur. Radiol. 19:May (5) (2009), 1206–1213.
27. Goéré, D., Deshaies, I., de Baere, T., Boige, V., Malka, D., Dumont, F., Dromain, C., Ducreux, M., Elias, D., Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann. Surg. 251:April (4) (2010), 686–691, 10.1097/SLA.0b013e3181d35983.
28. Groeschl, R.T., Pilgrim, C.H., Hanna, E.M., Simo, K.A., Swan, R.Z., Sindram, D., Martinie, J.B., Iannitti, D.A., Bloomston, M., Schmidt, C., Khabiri, H., Shirley, L.A., Martin, R.C., Tsai, S., Turaga, K.K., Christians, K.K., Rilling, W.S., Gamblin, T.C., Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann. Surg. 259:June (4) (2014), 1195–1200.
29. Hendlitz, A., Van den Eynde, M., Peeters, M., Maleux, G., Lambert, B., Vanoote, J., De Keukeleire, K., Verslype, C., Defreyne, L., Van Cutsem, E., Delatte, P., Delanoit, T., Personeni, N., paesmans, M., Ven Laethem, J.L., Flamen, P., Phase III trial compared protracetd intravenous fluorouracil infusion alone or with yttrium 90 resin microspheres radioembolization for liver limited metastatic colorectal refractory to standard chemitherapy. J. Clin. Oncol. 10:August (23) (2010), 3687–3694.
30. House, M.G., Kemeny, N.E., Gönen, M., Fong, Y., Allen, P.J., Paty, P.B., DeMatteo, R.P., Blumgart, L.H., Jarnagin, W.R., D'Angelica, M.I., Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. Ann. Surg. 254:December (6) (2011), 851–856.
31. Hugen, N., van de Velde, C.J., de Wilt, J.H., Nagtegaal, I.D., Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. Mar 25:3 (2014), 651–657.
32. Ihnát, P., Vávra, P., Zonča, P., Treatment strategies for colorectal carcinoma with synchronous liver metastases: which way to go?. World J. Gastroenterol. 21:June (22) (2015), 7014–7021.
33. Karanicolas, P.J., Jarnagin, W.R., Gonen, M., Tuorto, S., Allen, P.J., DeMatteo, R.P., D'Angelica, M.I., Fong, Y., Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg. 148:July (7) (2013), 597–601.
34. Kawato, Y., Aonuma, M., Hirota, Y., Kuga, H., Sato, K., Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 51:August (16) (1991), 4187–4191.
35. Kemeny, N.E., Gonen, M., Hepatic arterial infusion after liver resection. N. Engl. J. Med. 352 (2005), 734–735.
36. Kemeny, N., Daly, J., Reichman, B., Geller, N., Botet, J., Oderman, P., Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma A randomized trial. Ann Intern Med. 107:october (4) (1987), 459–465.
37. Kemeny, N., Huang, Y., Cohen, A.M., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med. 341 (1999), 2039–2048.
38. Kemeny, N., Gonen, M., Sullivan, D., Schwartz, L., Benedetti, F., Saltz, L., Stockman, J., Fong, Y., Jarnagin, W., Bertino, J., Tong, W., Paty, P., Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J. Clin. Oncol. 19:May (10) (2001), 2687–2695.
39. Kemeny, M.M., Adak, S., Gray, B., et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy–an intergroup study. J. Clin. Oncol. 20 (2002), 1499–1505.
40. Kemeny, N., Jarnagin, W., Gonen, M., Stockman, J., Blumgart, L., Sperber, D., Hummer, A., Fong, Y., Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J. Clin. Oncol. 21:September (17) (2003), 3303–3309.
41. Kemeny, N., Jarnagin, W., Paty, P., Gönen, M., Schwartz, L., Morse, M., Leonard, G., D'Angelica, M., DeMatteo, R., Blumgart, L., Fong, Y., Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J. Clin. Oncol. 23:August (22) (2005), 4888–4896.
42. Kemeny, N.E., Melendez, F.D., Capanu, M., Paty, P.B., Fong, Y., Schwartz, L.H., Jarnagin, W.R., Patel, D., D'Angelica, M., Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J. Clin. Oncol. 27:July (21) (2009), 3465–3471.
43. Kemeny, N., Capanu, M., D'Angelica, M., Jarnagin, W., Haviland, D., Dematteo, R., Fong, Y., Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann. Oncol. 20:July (7) (2009), 1236–1241.
44. Kemeny, N.E., Jarnagin, W.R., Capanu, M., Fong, Y., Gewirtz, A.N., Dematteo, R.P., D'Angelica, M.I., Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. J. Clin. Oncol. 29:March (7) (2011), 884–889.
45. Kerr, D.J., McArdle, C.S., Ledermann, J., Taylor, I., Sherlock, D.J., Schlag, P.M., Buckels, J., Mayer, D., Cain, D., Stephens, R.J., Medical Research Council's colorectal cancer study group, European Organisation for Research and Treatment of Cancer colorectal cancer study. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361:February (9355) (2003), 368–373.
46. Kingham, T.P., Correa-Gallego, C., D'Angelica, M.I., Gönen, M., DeMatteo, R.P., Fong, Y., Allen, P.J., Blumgart, L.H., Jarnagin, W.R., Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy. J. Am. Coll. Surg. 220:April (4) (2015), 471–479.
47. Ko, Y.J., Karanicolas, P.J., Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era. Curr Oncol 21:February (1) (2014), e116–21.
48. Lang, E.K., Brown, C.L. Jr., Colorectal metastases to the liver: selective chemoembolization. Radiology 189:November (2) (1993), 417–422.
49. Lencioni, R., Aliberti, C., de Baere, T., Garcia-Monaco, R., Narayanan, G., O'Grady, E., Rilling, W.S., Walker, D., Martin, R.C., Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. J. Vasc. Interv. Radiol. 25:March (3) (2014), 365–369.
50. Lim, L., Gibbs, P., Yip, D., Shapiro, J.D., Dowling, R., Smith, D., Little, A., Bailey, W., Liechtenstein, M., A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer, 15(October (5)), 2005, 132.
51. Llovet, J.M., Real, M.I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., Rodés, J., Bruix, J., Barcelona Liver Cancer Group, Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 18:May (9319) (2002), 1734–1739.
52. Lorenz, M., Muller, H.H., Schramm, H., et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann. Surg. 228 (1998), 756–762.
53. Lygidakis, N.J., Ziras, N., Parissis, J., Resection versus resection combined with adjuvant pre- and post-operative chemotherapy–immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterol 42 (1995), 155–161.
54. Mentha, G., Roth, A.D., Terraz, S., Giostra, E., Gervaz, P., Andres, A., Morel, P., Rubbia-Brandt, L., Majno, P.E., ‘Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig. Surg. 25:6 (2008), 430–435, 10.1159/000184734 Epub 2009 Feb 12.
55. Mocellin, S., Pilati, P., Lise, M., Nitti, D., Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?. J. Clin. Oncol. 10:December (35) (2007), 5649–5654.
56. Mulier, S., Mulier, P., Ni, Y., Miao, Y., Dupas, B., Marchal, G., De Wever, I., Michel, L., Complications of radiofrequency coagulation of liver tumours. Br. J. Surg. 89:October (10) (2002), 1206–1222.
57. Mulier, S., Ruers, T., Jamart, J., Michel, L., Marchal, G., Ni, Y., Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig. Surg. 25:6 (2008), 445–460, 10.1159/000184736.
58. Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G.J., Schlag, P.M., Rougier, P., Bechstein, W.O., Primrose, J.N., Walpole, E.T., Finch-Jones, M., Jaeck, D., Mirza, D., Parks, R.W., Mauer, M., Tanis, E., Van Cutsem, E., Scheithauer, W., Gruenberger, T., EORTC Gastro-Intestinal Tract Cancer Group, Cancer Research UK; Arbeitsgruppe Lebermetastasen und–tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD).Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 14:November (12) (2013), 1208–1215.
59. Parks, R., Gonen, M., Kemeny, N., Jarnagin, W., D'Angelica, M., Dematteo, R., Garden, O.J., Blumgart, L.H., Fong, Y., Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J. Am. Coll. Surg. 204:May (5) (2007), 753–761 discussion 761-3.
60. Pawlik, T.M., Abdalla, E.K., Ellis, L.M., Vauthey, J.N., Curley, S.A., Debunking dogma: surgery for four or more colorectal liver metastases is justified. J. Gastrointest. Surg. 10:February (2) (2006), 240–248.
61. Pawlik, T.M., Assumpcao, L., Vossen, J.A., Buijs, M., Gleisner, A.L., Schulick, R.D., Choti, M.A., Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases. Ann. Surg. Oncol. 16:February (2) (2009), 371–378.
62. Petre, E.N., Sofocleous, C.T., Solomon, S.B., Ablative and catheter-directed therapies for colorectal liver and lung metastases. Hematol. Oncol. Clin. North Am. 29:February (1) (2015), 117–133.
63. Portier, G., Elias, D., Bouche, O., Rougier, P., Bosset, J.F., Saric, J., Belghiti, J., Piedbois, P., Guimbaud, R., Nordlinger, B., Bugat, R., Lazorthes, F., Bedenne, L., Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J. Clin. Oncol. 24:November (31) (2006), 4976–4982.
64. Primrose, J., Falk, S., Finch-Jones, M., Valle, J., O'Reilly, D., Siriwardena, A., Hornbuckle, J., Peterson, M., Rees, M., Iveson, T., Hickish, T., Butler, R., Stanton, L., Dixon, E., Little, L., Bowers, M., Pugh, S., Garden, O.J., Cunningham, D., Maughan, T., Bridgewater J.Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. Lancet Oncol. 15:May (6) (2014), 601–611.
65. Rudroff, C., Altendorf-Hoffmann, A., Stangl, R., et al. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch. Surg. 384 (1999), 243–249.
66. Ruers, T., Punt, C.J.A., van Coevorden, F., Pierie, J.-P., Borel Rinkes, I., Ledermann, J., Poston, G., Bechstein, W., Lentz, M.-A., Mauer, M., Van Cutsem, E., Lutz, M., Nordlinger, B., Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC). Ann. Oncol., 26(suppl (4)), 2015, iv114.
67. Rule, W., Timmerman, R., Tong, L., Abdulrahman, R., Meyer, J., Boike, T., Schwarz, R.E., Weatherall, P., Chinsoo Cho, L., Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann. Surg. Oncol. 18:April (4) (2011), 1081–1087.
68. Sanz-Altamira, P.M., Spence, L.D., Huberman, M.S., Posner, M.R., Steele, G. Jr., Perry, L.J., Stuart, K.E., Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis. Colon Rectum 40:July (7) (1997), 770–775.
69. Scheffer, H.J., Nielsen, K., de Jong, M.C., van Tilborg, A.A., Vieveen, J.M., Bouwman, A.R., Meijer, S., van Kuijk, C., van den Tol, P.M., Meijerink, M.R., Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J. Vasc. Interv. Radiol. 25:July (7) (2014), 997–1011, 10.1016/j.jvir.2014.01.028 (quiz 1011 Epub 2014 Mar 18).
70. Seidensticker, R., Seidensticker, M., Damm, R., Mohnike, K., Schütte, K., Malfertheiner, P., Van Buskirk, M., Pech, M., Amthauer, H., Ricke, J., Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc. Intervent. Radiol. 35:October (5) (2012), 1109–1118.
71. Sharma, R.A., Van Hazel, G.A., Morgan, B., Berry, D.P., Blanshard, K., Price, D., et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J. Clin. Oncol. 25:March (9) (2007), 1099–1106.
72. Shibata, T., Niinobu, T., Ogata, N., Takami, M., Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89:July (2) (2000), 276–284.
73. Silberhumer, G.R., Paty, P.B., Temple, L.K., Araujo, R.L., Denton, B., Gonen, M., Nash, G.M., Allen, P.J., DeMatteo, R.P., Guillem, J., Weiser, M.R., D'Angelica, M.I., Jarnagin, W.R., Wong, D.W., Fong, Y., Simultaneous resection for rectal cancer with synchronous livermetastasis is a safe procedure. Am. J. Surg. 209:June (6) (2015), 935–942.
74. Solbiati, L., Ierace, T., Tonolini, M., Osti, V., Cova, L., Radiofrequency thermal ablation of hepatic metastases. Eur. J. Ultrasound 13:June (2) (2001), 149–158.
75. THER-RAD.00006, Selective Internal Radiation Therapy (SIRT) of Primary or Metastatic Liver Tumors. 2016 www.anthem.com/medicalpolicies.
76. Tanis, E., Nordlinger, B., Mauer, M., Sorbye, H., van Coevorden, F., Gruenberger, T., Schlag, P.M., Punt, C.J., Ledermann, J., Ruers, T.J., Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur. J. Cancer 50:March (5) (2014), 912–919.
77. Taylor, R.R., Tang, Y., Gonzalez, M.V., Stratford, P.W., Lewis, A.L., Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur. J. Pharm. Sci. 30:January (1) (2007), 7–14.
78. Tellez, C., Benson, A.B. 3rd, Lyster, M.T., Talamonti, M., Shaw, J., Braun, M.A., Nemcek, A.A. Jr., Vogelzang, R.L., Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82:April (7) (1998), 1250–1259.
79. Tomlinson, J.S., Jarnagin, W.R., DeMatteo, R.P., Fong, Y., Kornprat, P., Gonen, M., Kemeny, N., Brennan, M.F., Blumgart, L.H., D'Angelica, M., Actual 10-year survival after resection of colorectal liver metastases defines cure. J. Clin. Oncol. 25:October (29) (2007), 4575–4580.
80. Tono, T., Hasuike, Y., Ohzato, H., et al. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: a randomized study. Cancer 88 (2000), 1549–1556.
81. Van Cutsem, E., Cervantes, Nordlinger B3, Arnold D4 ESMO Guidelines Working Group. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 25(Suppl (3)), 2014 (iii1-9).
82. Van Hazel, G., Blackwell, A., Anderson, J., Price, D., Moroz, P., Bower, G., Cardaci, G., Gray, B., Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J. Surg. Oncol. 88:November (2) (2004), 78–85.
83. Van Hazel, G.A., Pavlakis, N., Goldstein, D., Olver, I.N., Tapner, M.J., Price, D., Bower, G.D., Briggs, G.M., Rossleigh, M.A., Taylor, D.J., George, J., Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J. Clin. Oncol. 27:September (25) (2009), 4089–4095.
84. Van Hazel, G.A., Heinemann, V., Sharma, N.K., Findlay, M.P.N., Ricke, J., Peeters, M., Perez, D., Robinson, B.A., Strickland, A.H., Ferguson, T., Rodrigez, J., Kröning, H., Wolf, I., Ganju, V., Walpole, E., Boucher, E., Tichler, T., Shacham-Shmueli, E., Powell, A., Eliadis, P., Isaacs, R., Price, D., Moeslein, F., Taieb, J., Bower, G., Gebski, V., Van Buskirk, M., Cade, D.N., Thurston, K., Gibbs, P., SIRFLOX. Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. J. Clin. Oncol. 20:May (15) (2016), 1723–1731.
85. Vente, M.A., Wondergem, M., van der Tweel, I., van den Bosch, M.A., Zonnenberg, B.A., Lam, M.G., Van Set Schip, A.D., Nijsen, J.F., Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur. Radiol. 19:April (4) (2009), 951–959, 10.1007/s00330-008.
86. Vogl, T.J., Gruber, T., Balzer, J.O., Eichler, K., Hammerstingl, R., Zangos, S., Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology 250:January (1) (2009), 281–289.
87. Vouche, M., Lewandowski, R.J., Atassi, R., Memon, K., Gates, V.L., Ryu, R.K., Gaba, R.C., Mulcahy, M.F., Baker, T., Sato, K., Hickey, R., Ganger, D., Riaz, A., Fryer, J., Caicedo, J.C., Abecassis, M., Kulik, L., Salem, R., Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J. Hepatol. 59:November (3) (2013), 1029–1036.
88. Wagman, L.D., Kemeny, M.M., Leong, L., et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J. Clin. Oncol. 8 (1990), 1885–1893.
89. Wong, S.L., Mangu, P.B., Choti, M.A., Crocenzi, T.S., Dodd 3rd, G.D., Dorfman, G.S., Eng, C., Fong, Y., Giusti, A.F., Lu, D., Marsland, T.A., Michelson, R., Poston, G.J., Schrag, D., Seidenfeld, J., Benson 3rd, A.B., American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J. Clin. Oncol. 20:January (3) (2010), 493–508.